NCT00780455 - Rehabilitation Study in MS Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

Interferon beta-1b, FRP within 15 days after randomization

Treatment by Interferon beta-1b (Betaseron, BAY86-5046) for 3 month and beginning of the Functional Rehabilitation Program starting within 6 weeks after randomization

DRUG

Interferon beta-1b, FRP about 6 weeks after randomization

Treatment by Interferon beta-1b (Betaseron, BAY86-5046) for 3 month and beginning of the Functional Rehabilitation Program about 6 weeks after randomization.

Trial Locations (10)

29000

Quimper

30029

Nîmes

31059

Toulouse

34295

Montpellier

35038

Rennes

51091

Reims

59037

Lille

59160

Lomme

68051

Mulhouse

84025

Avignon